Zhang, P., Zhang, X., Lang, J., Wu, S., Sun, Y., Wang, P., . . . Yi, J. (2024). Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: A propensity score matching real‐world study. Wiley. https://doi.org/10.1002/mco2.608
Citazione stile Chigago Style (17a edizione)Zhang, Peng, et al. Epidermal Growth Factor Receptor‑targeted Antibody Nimotuzumab Combined with Chemoradiotherapy Improves Survival in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Real‐world Study. Wiley, 2024. https://doi.org/10.1002/mco2.608.
Citatione MLA (9a ed.)Zhang, Peng, et al. Epidermal Growth Factor Receptor‑targeted Antibody Nimotuzumab Combined with Chemoradiotherapy Improves Survival in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Real‐world Study. Wiley, 2024. https://doi.org/10.1002/mco2.608.